HYPOTHYROIDISM AS A CONSEQUENCE OF INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT TAXANE-BASED CHEMOTHERAPY FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER
HYPOTHYROIDISM AS A CONSEQUENCE OF INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT TAXANE-BASED CHEMOTHERAPY FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER
复制标题
DOI:
10.1016/j.ijrobp.2009.05.018
复制
发表时间:
2010-06-01
影响因子:
7
通讯作者:
Cmelak, Anthony J.
中科院分区:
文献类型:
--
作者:
Diaz, Roberto;Jaboin, Jerry J.;Cmelak, Anthony J.
Purpose: To conduct a retrospective review of 168 consecutively treated locally advanced head-and-neck cancer (LAHNC) patients treated with intensity-modulated radiotherapy (IMRT)/chemotherapy, to determine the rate and risk factors for developing hypothyroidism.Methods and Materials: Intensity-modulated radiotherapy was delivered in 33 daily fractions to 69.3 Gy to gross disease and 56.1 Gy to clinically normal cervical nodes. Dose volume histograms (DVHs) of IMRT plans were used to determine radiation dose to thyroid and were compared with DVHs using conventional three-dimensional radiotherapy (3D-RT) in 10 of these same patients randomly selected for replanning and with DVHs of 16 patients in whom the thyroid was intentionally avoided during IMRT. Weekly paclitaxel (30 mg/m(2)) and carboplatin area under the curve-1 were given concurrently with IMRT.Results: Sixty-one of 128 evaluable patients (47.7%) developed hypothyroidism after a median of 1.08 years after IMRT (range, 2.4 months to 3.9 years). Age and volume of irradiated thyroid were associated with hypothyroidism development after IMRT. Compared with 3D-RT, IMRT with no thyroid dose constraints resulted in significantly higher minimum, maximum, and median dose (p